Periodontal Treatment
Scientific background
Periodontal disease is characterised by the destruction of periodontal tissue. If non-surgical, Phase I treatment such as patient education, plaque control, scaling and root planing fails, further surgical solutions are required.
The use of biomaterials for guided tissue regeneration (GTR) is more effective than open flap debridement alone in resolving periodontal defects1. During this procedure the defect is filled with the natural bone substitute Geistlich Bio-Oss® (Collagen) and covered with the collagen membrane Geistlich Bio-Gide® (Perio).
Natural bone substitute should:
- Fill the osseous defect and reduce pocket depth
- Generate increased levels of clinical attachment
- Stimulate regeneration and preservation of patient’s own bone and periodontal ligament
Collagen barrier membranes should:
- Stabilise the grafted area and protecting bone particles from dislocation5
- Prevent soft tissue ingrowth to the defect6-10
- Serve as a framework for bone cells and blood vessels6,8
References:
- Sculean A et al., J Clin Periodontol. 2007 Jan;34(1):72-77 (Clinical study). 37
- Newman MG, et al., Caranza's Clinical Periodontology. Elsevier (Book).
- Lindhe J, et al., Clinical Periodontology and Implant Dentistry. Blackwell Munksgaard (Book).
- Rateitschak EM, Wolf HF, Farbatlanten der Zahnmedizin. Band 1: Parodontologie. Thieme (Book)
- Perelman-Karmon M et al. Int J Periodontics Restorative Dent. 2012 Aug;32(4):459-65. (Clinical study)
- Schwarz F et al. Clin. Oral Implants Res. 2006;17(4):403-409. (Pre-clinical study)
- Tal H et al. Clin Oral Implants Res. 2008; 19(3) : 295-302. (Clinical study)
- Rothamel D et al. Clin. Oral Implants Res. 2005; 16(3): 369-378. (Pre-clinical study)
- Zitzmann NU et al. Int J Oral Maxillofac Implants.12, 1997;844-852. (Clinical study)
- Rothamel D et al. Clin. Oral Implants Res. 2004;15:443-449. (Pre-clinical study)
Higher attachment gain with Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio
The use of a Geistlich bone substitute material together with native collagen membrane Geistlich Bio-Gide® Perio produces significantly better results than open flap debridement alone. Five-year data show higher clinical attachment level gains and greater pocket depth reduction1.
References:
- Sculean A et al., J Clin Periodontol. 2007 Jan;34(1):72-77 (Clinical study). 37
- Newman MG, et al., Caranza's Clinical Periodontology. Elsevier (Book)
- Lindhe J, et al., Clinical Periodontology and Implant Dentistry. Blackwell Munksgaard (Book).
- Rateitschak EM, Wolf HF, Farbatlanten der Zahnmedizin. Band 1: Parodontologie. Thieme (Book)
- Perelman-Karmon M et al. Int J Periodontics Restorative Dent. 2012 Aug;32(4):459-65. (Clinical study)
- Schwarz F et al. Clin. Oral Implants Res. 2006;17(4):403-409. (Pre-clinical study)
- Tal H et al. Clin Oral Implants Res. 2008; 19(3) : 295-302. (Clinical study)
- Rothamel D et al. Clin. Oral Implants Res. 2005; 16(3): 369-378. (Pre-clinical study)
- Zitzmann NU et al. Int J Oral Maxillofac Implants.12, 1997;844-852. (Clinical study)
- Rothamel D et al. Clin. Oral Implants Res. 2004;15:443-449. (Pre-clinical study)
Clinical Cases
Treatment in the aesthetic area
Clinical case
Anterior maxillary periodontal regeneration in the aesthetic region: resolving gingival recession and preventing tooth hypermobility.
Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio support re-establishment of full functional attachment.
Treatment in the posterior area
Clinical case
Posterior periodontal regeneration: resolving an extended three-wall defect caused by a cemental tear.
Geistlich Bio-Oss® and Geistlich Bio-Gide® Perio help restore soft and hard tissue.
Treatment in the mandibular front area
Clinical case
Anterior mandible periodontal regeneration: resolving an extended two-wall defect.
The combination of Geistlich Bio-Oss® Collagen and Geistlich Bio-Gide® Perio promotes and guides tissue regeneration.
Product efficacy demonstrated in about 1,400 scientific publications
Decades of experience with biomaterials and pioneering work achieved are documented in meaningful scientific evidence. The efficacy of Geistlich’s biomaterials is documented in about 1,400 scientific publications – when it comes to the safety and quality of its products, Geistlich doesn’t compromise. To learn from the best and gain valuable expertise, the company networks with renowned international experts, university partners and esteemed clinical practitioners. New treatment concepts and products are born from the exchanges between this network of expertise. Geistlich places great importance on training medical professionals. The strive for excellence means that a Geistlich biomaterial is used every 15 seconds around the world.